Business Context and Reporting Period
This Form 8-K Current Report was filed by Nephros, Inc. on March 3, 2006, covering events occurring on March 3, 2006, and March 8, 2006. The filing primarily addresses a material change in executive leadership and the execution of a new employment agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and compensation terms.
Material Changes
- Appointment of CFO: Mark W. Lerner was appointed Chief Financial Officer (Principal Financial and Accounting Officer), effective March 6, 2006.
- Departure of Interim CFO: Mr. Lerner replaces Bruce Prashker, who served as Interim CFO through February 24, 2006.
- Compensation Agreement: Mr. Lerner's employment terms include a base salary of $175,000 per year and a potential bonus of up to 20% of base salary (or more) based on performance objectives.
- Equity Grant: Mr. Lerner received an option to purchase 40,000 shares of common stock, vesting 25% on the grant date and 25% annually for the next three years.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of material risks and contingencies. It notes that a press release regarding the appointment was issued on March 8, 2006, and clarifies that the information in Item 8.01 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the effective date of the CFO transition (March 6, 2006) and the departure of the interim officer.
- Confirm the vesting schedule and grant date for the 40,000 stock options awarded to the new CFO.
- Review the specific performance objectives required to trigger the bonus component of the new CFO's compensation.
- Check subsequent filings for the first financial statements prepared under the new CFO's oversight.